- Antibodies
- New
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Tag
- Peptides
- Biological Process >
- Cellular Compartment >
- Disease >
- Molecular Function >
- Pathway Biocarta >
- Pathway KEGG >
- Pathway Panther >
- Tissue >
- Amino Acids
- Tag
- Biological Process >
- Proteins
- RNAi
- FL cDNA Clones
- Cell/Tissues/Lysates
Kallikrein 3 Antibody (C-term)Purified Rabbit Polyclonal Antibody (Pab)
| Country | United States
Ordering Information
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others 
|
|||
|---|---|---|---|---|
| Catalog # | Size | Availability | Price | |
| AP6322b | 0.1 mg 400 ul | In Stock | $ 255.00 | DISCONTINED INQUIRE CLICK INQUIRE Add to cart |
- Specification
- Citiations : 0
- Reviews
- Protocols
- Backgrounds
Kallikrein 3 Antibody (C-term) - Product info | |
| Application | WB
|
| Primary Accession | P07288 |
| Reactivity | Human |
| Concentration | 0.25 mg/ml |
| Isotype | Rabbit Ig |
| Calculated MW | 28741 Da |
Kallikrein 3 Antibody (C-term) - Additional info | |
| Gene ID 354 | |
| Other Names KLK3; APS; Prostate-specific antigen; Gamma-seminoprotein; Kallikrein-3; P-30 antigen; Semenogelase | |
| Target/Specificity This Kallikrein 3 Antibody antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 227~257 amino acids from the C-terminal region of human KLK3. | |
| Dilution WB~~1:100~500WB~~1:1000 | |
| Format Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS. | |
| Storage Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. | |
| Precautions Kallikrein 3 Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures. | |
Kallikrein 3 Antibody (C-term) - Protein Information | |
| Name KLK3 | |
| Synonyms APS | |
| Function Hydrolyzes semenogelin-1 thus leading to the liquefaction of the seminal coagulum | |
| Cellular Location Secreted. | |
Kallikrein 3 Antibody (C-term) - Related products
AP6322b: Kallikrein 3 Antibody (C-term)
DC01716: Human KLK3 cDNA Clone
LY11024a: KLK3 Over-expression Lysate
Kallikrein 3 Antibody (C-term) - Application data
-
Western blot analysis of anti-KLK3 Pab (Cat. #AP6322b) in mouse brain tissue lysate.KLK3(arrow) was detected using the purified Pab.
Kallikrein 3 Antibody (C-term) - Research Areas
Abgent welcomes feedback from its customers.
If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abgent.com.
Thank you for your support.
Provided below are standard protocols that you may find useful for product applications.
BACKGROUND
Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. KLK3 is a protease present in seminal plasma. It is thought to function normally in the liquefaction of seminal coagulum, presumably by hydrolysis of the high molecular mass seminal vesicle protein. Serum level of this protein, called PSA in the clinical setting, is useful in the diagnosis and monitoring of prostatic carcinoma.
REFERENCES
Binnie, M.C., et al., Prostate 63(4):309-315 (2005). Habib, F.K., et al., Int. J. Cancer 114(2):190-194 (2005). Laidler, P., et al., Arch. Biochem. Biophys. 435(1):1-14 (2005). Dallas, S.L., et al., J. Cell. Physiol. 202(2):361-370 (2005). Olsson, A.Y., et al., Genomics 84(1):147-156 (2004).
